Kevin Norrett is Chief Business Officer of SOLENO THERAPEUTICS INC. Currently has a direct ownership of 14,286 shares of SLNO, which is worth approximately $706,014. The most recent transaction as insider was on Nov 17, 2025, when has been sold 14,286 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 14.3K
n/a 3M change
n/a 12M change
Total Value Held $706,014

Kevin Norrett Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 17 2025
BUY
Grant, award, or other acquisition
-
14,286 Added 50.0%
14,286 Common Stock

Also insider at

SRRA
Sierra Oncology, Inc. Healthcare
CDXS
CODEXIS, INC. Healthcare
KN

Kevin Norrett

Chief Business Officer
San Mateo, CA

Track Institutional and Insider Activities on SLNO

Follow SOLENO THERAPEUTICS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SLNO shares.

Notify only if

Insider Trading

Get notified when an Soleno Therapeutics Inc insider buys or sells SLNO shares.

Notify only if

News

Receive news related to SOLENO THERAPEUTICS INC

Track Activities on SLNO